Concepedia

Jenny Ahn

JA

Statistics

Publications

3

Citations

63

H-Index

3

Active since

2018

Affiliations

Oregon Health & Science University(Current)

Jenny Ahn is an author at Oregon Health & Science University specializing in pharmacotherapy, pharmacology, and antiviral pharmacotherapy.

Publications per year

2018–2024

3

Publications

3

Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab

Bryant D. Yang, Jennifer A. Fulcher, Jenny Ahn et al. · Clinical Infectious Diseases · 2020 · 36 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Safety and efficacy of pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC).

David B. Page, Isaac K Kim, Katherine Sanchez et al. · Journal of Clinical Oncology · 2018 · 14 citations

Medicine, Pharmacology, Pharmacotherapy +17

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

Kanal Singh, Kevin Rubenstein, Viviane Callier et al. · The Journal of Infectious Diseases · 2024 · 13 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

1–3 of 3